MedTrace Logo

Goal Attainment and Physical Activity in People With Hemophilia A

NCT06530030 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2026-01-20

No results posted yet for this study

Summary

This is a Phase 4, multi-center, observational study conducted in patients aged 12 to 50 years with moderate or severe hemophilia A who are newly starting prophylaxis with efa in the US and Japan.

This study aims to enroll 35 patients.

Conditions

Interventions

DRUG

efanesoctocog alfa

All treatment decisions must be made independent of study participation and study-related visits/assessments are not intended to inform treatment decisions. No study medication is provided as part of study participation.

Sponsors & Collaborators

Eligibility

Min Age
12 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-26
Primary Completion
2025-09-18
Completion
2025-09-18
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06530030 on ClinicalTrials.gov